Advertisement
To participate in the conference call, please dial 888-684-1280 fordomestic callers and 913-312-0952 for international callers. A telephonereplay of the conference call will be available through Friday, November 14,2008. To access the replay, please dial 888-203-1112 for domestic callers and719-457-0820 for international callers and reference conference replaypasscode 1268443.
Advertisement
In addition, interested parties may access a live audio webcast of thepresentation from the investor section of the VIA website,http://www.viapharmaceuticals.com. A replay of the presentation will bearchived on the VIA website for 30 days following the presentation.
About VIA Pharmaceuticals, Inc.
VIA Pharmaceuticals, Inc. is a biotechnology company focused on thedevelopment of compounds for the treatment of cardiovascular disease. VIA isbuilding a pipeline of small-molecule drugs that target a significant unmetmedical need: reducing inflammation in the blood vessel wall, which is anunderlying cause of atherosclerosis and its complications, including heartattack and stroke. The company's lead drug candidate, VIA-2291, is in multiplePhase 2 clinical studies in patients with cardiovascular disease. For moreinformation, visit: http://www.viapharmaceuticals.com.
SOURCE VIA Pharmaceuticals, Inc.
